{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:19:04Z","timestamp":1789885144094,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI093772"],"award-info":[{"award-number":["AI093772"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI134132"],"award-info":[{"award-number":["AI134132"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI105170"],"award-info":[{"award-number":["AI105170"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.virol.2019.01.017","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T07:56:18Z","timestamp":1547538978000},"page":"111-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles"],"prefix":"10.1016","volume":"529","author":[{"given":"Young-Tae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Na","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Suk","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-5689","authenticated-orcid":false,"given":"Daniel R.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2019.01.017_bib1","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1128\/JVI.00679-09","article-title":"Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner","volume":"83","author":"Abe","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.017_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4049\/jimmunol.171.3.1133","article-title":"Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice","volume":"171","author":"Abe","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2019.01.017_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/252252a0","article-title":"Liposomes as immunological adjuvants","volume":"252","author":"Allison","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.virol.2019.01.017_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virusres.2004.02.031","article-title":"Current status of live attenuated influenza virus vaccine in the US","volume":"103","author":"Belshe","year":"2004","journal-title":"Virus Res."},{"issue":"Suppl. 4","key":"10.1016\/j.virol.2019.01.017_bib5","doi-asserted-by":"crossref","first-page":"SD10","DOI":"10.1016\/j.vaccine.2008.06.083","article-title":"Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age","volume":"26","author":"Belshe","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.01.017_bib6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2019.01.017_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.virol.2019.01.017_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000149703","article-title":"Autographa californica nuclear polyhedrosis virus efficiently enters but does not replicate in poikilothermic vertebrate cells","volume":"26","author":"Brusca","year":"1986","journal-title":"Intervirology"},{"key":"10.1016\/j.virol.2019.01.017_bib9","first-page":"1721","article-title":"A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children","volume":"12","author":"Caspard","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.virol.2019.01.017_bib10","unstructured":"CDC. Seasonal Influenza Vaccine Effectiveness, 2005\u20132018. \u3008https:\/\/www.cdc.gov\/flu\/professionals\/vaccination\/effectiveness-studies.htm\u3009."},{"key":"10.1016\/j.virol.2019.01.017_bib11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/eji.200535217","article-title":"Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza","volume":"36","author":"Deliyannis","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2019.01.017_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.virol.2019.01.017_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2019.01.017_bib14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2019.01.017_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/mi.2017.14","article-title":"M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection","volume":"11","author":"Eliasson","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.virol.2019.01.017_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1743-422X-3-102","article-title":"Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2","volume":"3","author":"Feng","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2019.01.017_bib17","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.virol.2019.01.017_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2013 United States, 2017\u201318 influenza season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.virol.2019.01.017_bib19","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2019.01.017_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.virol.2017.08.023","article-title":"Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens","volume":"511","author":"Heinimaki","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.01.017_bib21","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2019.01.017_bib22","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1128\/JVI.05406-11","article-title":"H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans","volume":"85","author":"Khurana","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.017_bib23","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/mt.2014.33","article-title":"Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection","volume":"22","author":"Kim","year":"2014","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.virol.2019.01.017_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","volume":"21","author":"Kim","year":"2013","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.virol.2019.01.017_bib25","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1128\/JVI.00339-16","article-title":"Effects of MF59 adjuvant on induction of isotype-switched IgG antibodies and protection after immunization with T-dependent influenza virus vaccine in the absence of CD4+ T cells","volume":"90","author":"Ko","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.017_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.antiviral.2018.08.017","article-title":"Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice","volume":"158","author":"Kolpe","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.01.017_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4110\/in.2015.15.5.213","article-title":"Mechanisms of cross-protection by influenza virus M2-based vaccines","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw."},{"key":"10.1016\/j.virol.2019.01.017_bib28","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4049\/jimmunol.1501637","article-title":"A novel vaccination strategy mediating the induction of lung-resident memory CD8 T cells confers heterosubtypic immunity against future pandemic influenza virus","volume":"196","author":"Lee","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2019.01.017_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imm.12310","article-title":"Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination","volume":"143","author":"Lee","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.virol.2019.01.017_bib30","doi-asserted-by":"crossref","first-page":"e0190868","DOI":"10.1371\/journal.pone.0190868","article-title":"Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2019.01.017_bib31","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1128\/JVI.00605-16","article-title":"CD47 plays a role as a negative regulator in inducing protective immune responses to vaccination against influenza virus","volume":"90","author":"Lee","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.017_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1074-7613(03)00023-2","article-title":"Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection","volume":"18","author":"Legge","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2019.01.017_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micinf.2004.10.006","article-title":"Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design","volume":"7","author":"Liu","year":"2005","journal-title":"Microbes Infect."},{"key":"10.1016\/j.virol.2019.01.017_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/hv.18757","article-title":"Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic","volume":"8","author":"Lopez-Macias","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.virol.2019.01.017_bib35","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.vaccine.2011.07.099","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico","volume":"29","author":"Lopez-Macias","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.01.017_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.017_bib37","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1128\/JVI.00748-14","article-title":"Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination","volume":"88","author":"O","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.017_bib38","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMp058068","article-title":"Preparing for the next pandemic","volume":"352","author":"Osterholm","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.virol.2019.01.017_bib39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature04267","article-title":"Control of B-cell responses by toll-like receptors","volume":"438","author":"Pasare","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2019.01.017_bib40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/JVI.01503-10","article-title":"Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses","volume":"85","author":"Pena","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.017_bib41","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.01615-07","article-title":"Induction of heterosubtypic immunity to influenza virus by intranasal immunization","volume":"82","author":"Quan","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.01.017_bib42","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1016\/j.vaccine.2016.08.082","article-title":"Squalene-containing licensed adjuvants enhance strain-specific antibody responses against the influenza hemagglutinin and induce subtype-specific antibodies against the neuraminidase","volume":"34","author":"Schmidt","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.01.017_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.amepre.2016.02.027","article-title":"Cost effectiveness of influenza vaccine for U.S. children: live attenuated and inactivated influenza vaccine","volume":"51","author":"Shim","year":"2016","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.virol.2019.01.017_bib44","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.virol.2019.01.017_bib45","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1021\/pr200086v","article-title":"Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity","volume":"10","author":"Song","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.virol.2019.01.017_bib46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.antiviral.2010.09.001","article-title":"Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles","volume":"88","author":"Song","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.01.017_bib47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1012199108","article-title":"Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus","volume":"108","author":"Song","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2019.01.017_bib48","first-page":"1","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.virol.2019.01.017_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0042-6822(83)90067-3","article-title":"Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells","volume":"125","author":"Tjia","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.01.017_bib50","first-page":"1153","article-title":"Preliminary estimates of mortality and years of life lost associated with the 2009 A\/H1N1 pandemic in the US and comparison with past influenza seasons","author":"Viboud","year":"2010","journal-title":"PLoS Curr. RRN"},{"key":"10.1016\/j.virol.2019.01.017_bib51","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jit811","article-title":"Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans","volume":"209","author":"Zhong","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2019.01.017_bib52","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014\u20132015 Influenza vaccine effectiveness in the United States by vaccine type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin. Infect. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219300170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219300170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:48:40Z","timestamp":1758588520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682219300170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"alternative-id":["S0042682219300170"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2019.01.017","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2019.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}